Biology of HIV mucosal transmission

Current Opinion in HIV and AIDS

Volumn 3, Issue 5, 2008, Pages 534-540

  Wu, Li ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Biology; HIV; Infection; Mucosal; Transmission

Indexed keywords

AMYLOID; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CARBOHYDRATE; CD34 ANTIGEN; CD4 ANTIGEN; CELL MEMBRANE PROTEIN; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LANGERIN; LECTIN; MICROBICIDE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; SYNDECAN 3; TETHERIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ADAPTIVE IMMUNITY; APOPTOSIS; BIOMECHANICS; CD4+ T LYMPHOCYTE; CELL JUNCTION; CROSS PRESENTATION; CYTOKINE PRODUCTION; DENDRITIC CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION PREVENTION; INNATE IMMUNITY; INTERFERON PRODUCTION; INTESTINE MUCOSA; LANGERHANS CELL; MACROPHAGE; MICROBIOLOGY; MUCOSA; NONHUMAN; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; REVIEW; SEMINAL PLASMA; SEXUAL TRANSMISSION; TARGET CELL; VAGINA MUCOSA; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS CULTURE; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

EID: 54049089700     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e32830634c6     Document Type: Review

References (76)

1. Wu L, KewalRamani VN. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat Rev Immunol 2006; 6:859-868.
2. Lederman MM, Offord RE, Hartley O. Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat Rev Immunol 2006; 6:371-382.
3. Morrow G, Vachot L, Vagenas P, et al. Current concepts of HIV transmission. Curr HIV/AIDS Rep 2007; 4:29-35. An interesting review highlights current understanding of HIV-1 mucosal transmission.
4. + T cells.
5. Turville SG, Santos JJ, Frank I, et al. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 2004; 103:2170-2179.
6. Turville SG, Vermeire K, Balzarini J, et al. Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer. J Virol 2005; 79:13519-13527.
7. Wang JH, Janas AM, Olson WJ, et al. Functionally distinct transmission of human immunodeficiency virus type 1 mediated by immature and mature dendritic cells. J Virol 2007; 81:8933-8943. A functional comparative study shows distinct efficiencies and mechanisms of HIV-1 trans-infection mediated by immature and mature dendritic cells. This study also reports dendritic cell-target cell contact is required for dendritic cell-mediated HIV-1 transmission.
8. Izquierdo-Useros N, Blanco J, Erkizia I, et al. Maturation of blood derived dendritic cells enhances HIV-1 capture and transmission. J Virol 2007; 81:7559-7570.
9. Dong C, Janas AM, Wang J-H, et al. Characterization of human immunodeficiency virus type 1 replication in immature and mature dendritic cells reveals dissociable cis- and trans-infection. J Virol 2007; 81:11352-11362. This report is a comparative analysis of cis and trans-infections of HIV-1 mediated by different dendritic cell subsets, suggesting that these two infection pathways are dissociable.
10. Fahrbach KM, Barry SM, Ayehunie S, et al. Activated CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus. J Virol 2007; 81:6858-6868.
11. Frank I, Stossel H, Getti A, et al. A fusion inhibitor prevents dendritic cell (DC) spread of immunodeficiency viruses but not DC activation of virus-specific T cells. J Virol 2008; 82:5329-5339.
12. de Witte L, Nabatov A, Pion M, et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 2007; 13:367-371. This study showed that langerin mediates HIV-1 internalization and intracellular degradation in skin-derived Langerhans cells, thereby inhibiting HIV-1 replication and transmission.
13. Kawamura T, Koyanagi Y, Nakamura Y, et al. Significant virus replication in Langerhans cells following application of HIV to abraded skin: relevance to occupational transmission of HIV. J Immunol 2008; 180:3297-3304. A report indicates that epithelial Langerhans cells account for over 95% of HIV-1 dissemination in human skin explants.
14. Cavrois M, Neidleman J, Kreisberg JF, et al. In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions. PLoS Pathog 2007; 3:e4.
15. Bobardt MD, Chatterji U, Selvarajah S, et al. Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J Virol 2007; 81:395-405.
16. Piguet V, Steinman RM. The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol 2007; 28:503-510.
17. McDonald D, Wu L, Bohks SM, et al. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 2003; 300:1295-1297.
18. Piguet V, Sattentau Q. Dangerous liaisons at the virological synapse. J Clin Invest 2004; 114:605-610.
19. Boggiano C, Manel N, Littman DR. Dendritic cell-mediated transenhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN. J Virol 2007; 81:2519-2523.
20. de Witte L, Bobardt M, Chatterji U, et al. Syndecan-3 is a dendritic cellspecific attachment receptor for HIV-1. Proc Natl Acad Sci U S A 2007; 104:19464-19469.
21. Smith AL, Ganesh L, Leung K, et al. Leukocyte-specific protein 1 interacts with DC-SIGN and mediates transport of HIV to the proteasome in dendritic cells. J Exp Med 2007; 204:421-430.
22. Hodges A, Sharrocks K, Edelmann M, et al. Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nat Immunol 2007; 8:569-577.
23. Gringhuis SI, den Dunnen J, Litjens M, et al. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 2007; 26:605-616.
24. Garcia E, Pion M, Pelchen-Matthews A, et al. HIV-1 trafficking to the dendritic cell-T-cell infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse. Traffic 2005; 6:488-501.
25. Wiley RD, Gummuluru S. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc Natl Acad Sci U S A 2006; 103:738-743.
26. Garcia E, Nikolic DS, Piguet V. HIV-1 replication in dendritic cells occurs via a tetraspanin-containing compartment enriched in AP-3. Traffic 2008; 9:200-214.
27. Groot F, van Capel TM, Schuitemaker J, et al. Differential susceptibility of naive, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission. Retrovirology 2006; 3:52.
28. + T cells, suggesting a role of dendritic cells in R5 HIV-1 selection during parenteral transmission.
29. Wang JH, Janas AM, Olson WJ, et al. CD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1. J Virol 2007; 81:2497-2507. This study suggested that HIV-1 Nef enhances dendritic cell-mediated HIV-1 transmission, and that CD4 coexpression modulates DC-SIGN-mediated viral transmission.
30. Nobile C, Petit C, Moris A, et al. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J Virol 2005; 79:5386-5399.
31. Cavrois M, Neidleman J, Kreisberg JF, et al. Human immunodeficiency virus fusion to dendritic cells declines as cells mature. J Virol 2006; 80:1992-1999.
32. Burleigh L, Lozach P-Y, Schiffer C, et al. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells. J Virol 2006; 80:2949-2957.
33. Pion M, Arrighi JF, Jiang J, et al. Analysis of HIV-1-X4 fusion with immature dendritic cells identifies a specific restriction that is independent of CXCR4 levels. J Invest Dermatol 2007; 127:319-323.
34. Janas AM, Dong C, Wang JH, et al. Productive infection of human immunodeficiency virus type 1 in dendritic cells requires fusion-mediated viral entry. Virology 2008; 375:442-451.
35. Moris A, Nobile C, Buseyne F, et al. DC-SIGN promotes exogenous MHC-Irestricted HIV-1 antigen presentation. Blood 2004; 103:2648-2654.
36. Schindler M, Munch J, Kutsch O, et al. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 2006; 125:1055-1067.
37. Duvall MG, Lore K, Blaak H, et al. Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection. J Virol 2007; 81:13486-13498.
38. Chen P, Hubner W, Spinelli MA, et al. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J Virol 2007; 81:12582-12595. This study estimated that cell-associated transfer of HIV-1 through virological synapses can be 92 to 18 600-fold more efficient than that of cell-free virus.
39. Jolly C, Mitar I, Sattentau QJ. Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1. J Virol 2007; 81:5547-5560.
40. Jolly C, Mitar I, Sattentau QJ. Adhesion molecule interactions facilitate human immunodeficiency virus type 1-induced virological synapse formation between T cells. J Virol 2007; 81:13916-13921.
41. Sol-Foulon N, Sourisseau M, Porrot F, et al. ZAP-70 kinase regulates HIV cell-to-cell spread and virological synapse formation. EMBO J 2007; 26:516-526.
42. + T cells. The efficiency of HIV-1 transmission by nanotubes remains to be determined when compare to virological synapse-mediated viral transfer.
43. Groot F, Welsch S, Sattentau QJ. Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. Blood 2008; 111:4660-4663.
44. + T cells through virological synapses.
45. Jouvenet N, Neil SJ, Bess C, et al. Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol 2006; 4:e435.
46. Welsch S, Keppler OT, Habermann A, et al. HIV-1 buds predominantly at the plasmamembrane of primary human macrophages. PLoS Pathog 2007; 3:e36.
47. Deneka M, Pelchen-Matthews A, Byland R, et al. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J Cell Biol 2007; 177:329-341.
48. Jouve M, Sol-Foulon N, Watson S, et al. HIV-1 buds and accumulates in "nonacidic" endosomes of macrophages. Cell Host Microbe 2007; 2:85-95. An ultrastructural study suggested that HIV-1 survives within a nonacidic assembly compartment preventing intracellular degradation.
49. Savina A, Jancic C, Hugues S, et al. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 2006; 126:205-218.
50. Pollicita M, Schols D, Aquaro S, et al. Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes. Virology 2008; 370:382-391.
51. Swingler S, Mann AM, Zhou J, et al. Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog 2007; 3:1281-1290.
52. Chugh P, Bradel-Tretheway B, Monteiro-Filho CM, et al. Akt inhibitors as an HIV-1 infected macrophage-specific antiviral therapy. Retrovirology 2008; 5:11.
53. Lama J, Planelles V. Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology 2007; 4:52. This is a comprehensive review on host factors affecting susceptibility to HIV infection and AIDS progression.
54. Münch J, Rucker E, Standker L, et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007; 131:1059-1071. This study reported that human semen-derived amyloid fibrils can enhance HIV-1 infectivity by more than 100 000-fold under the experimental conditions. The mechanisms underlying the formation of the amyloid fibrils and the enhancement of HIV-1 infectivity remain to be elucidated.
55. Sabatté J, Ceballos A, Raiden S, et al. Human seminal plasma abrogates the capture and transmission of human immunodeficiency virus type 1 to CD4+ T cells mediated by DC-SIGN. J Virol 2007; 81:13723-13734.
56. Groot F, van Capel TM, Kapsenberg ML, et al. Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition. Blood 2006; 108:1957-1964.
57. Meyers JH, Justement JS, Hallahan CW, et al. Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cells. PLoS ONE 2007; 2:e458. A study suggested that plasmacytoid dendritic cells can be important mediators of innate anti-HIV-1 immunity.
58. Pion M, Granelli-Piperno A, Mangeat B, et al. APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection. J Exp Med 2006; 203:2887-2893.
59. Peng G, Greenwell-Wild T, Nares S, et al. Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 2007; 110:393-400.
60. Wang FX, Huang J, Zhang H, et al. APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells. J Gen Virol 2008; 89:722-730.
61. Martinelli E, Cicala C, Van Ryk D, et al. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-a secretion in plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 2007; 104:3396-3401. This study suggested that HIV-1 gp120 antagonizes the innate anti-HIV-1 activity of plasmacytoid dendritic cells.
62. Naghavi MH, Goff SP. Retroviral proteins that interact with the host cell cytoskeleton. Curr Opin Immunol 2007; 19:402-407.
63. Dustin ML. Cell adhesion molecules and actin cytoskeleton at immune synapses and kinapses. Curr Opin Cell Biol 2007; 19:529-533.
64. Fackler OT, Alcover A, Schwartz O. Modulation of the immunological synapse: a key to HIV-1 pathogenesis? Nat Rev Immunol 2007; 7:310-317.
65. Thoulouze MI, Sol-Foulon N, Blanchet F, et al. Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity 2006; 24:547-561.
66. Brass AL, Dykxhoorn DM, Benita Y, et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008; 319:921-926. A new study reported over 250 cellular proteins that are required for HIV-1 replication. Despite using a HeLa-cell-derived cell line in the genomic screen, this study provided new insights into further studies of HIV-host interactions.
67. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008; 451:425-430. A host protein termed tetherin is found to inhibit retrovirus release from the cell surface, while HIV-1 Vpu counteracts tetherin's antiviral function. Thus, inhibition of Vpu function could be a potential therapeutic strategy against HIV-1 infection.
68. Van Damme N, Goff D, Katsura C, et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008; 3:245-252.
69. Iwasaki A. Mucosal dendritic cells. Annu Rev Immunol 2007; 25:381-418.
70. Moris A, Pajot A, Blanchet F, et al. Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood 2006; 108:1643-1651.
71. Jones L, McDonald D, Canaday DH. Rapid MHC-II antigen presentation of HIV type 1 by human dendritic cells. AIDS Res Hum Retroviruses 2007; 23:812-816.
72. Shan M, Klasse PJ, Banerjee K, et al. HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells. PLoS Pathog 2007; 3:e169.
73. van Montfort T, Nabatov AA, Geijtenbeek TB, et al. Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes. J Immunol 2007; 178:3177-3185.
74. Dolan MJ, Kulkarni H, Camargo JF, et al. CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entryindependent mechanisms. Nat Immunol 2007; 8:1324-1336. This study suggested that host factors CCL3L1 and CCR5 influence viral pathogenesis through cell-mediated immunity and viral entry-independent mechanisms.
75. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371.
76. + T cells via HIV-1 gp120 activates or leukocyte function-associated antigen-1, which facilitates VSmediated cell-cell transmission of HIV-1.